Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Brain GABA levels in patients with bipolar disorder.

Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE, Renshaw PF, Pollack MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):427-34. doi: 10.1016/j.pnpbp.2008.12.025. Epub 2009 Jan 10.

PMID:
19171176
2.

High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.

Pollack MH, Jensen JE, Simon NM, Kaufman RE, Renshaw PF.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):739-43. doi: 10.1016/j.pnpbp.2007.11.023. Epub 2007 Nov 28.

PMID:
18206286
3.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
4.

Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.

Soeiro-de-Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa Leite C, Vallada H, Otaduy MC.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2221-9. doi: 10.1016/j.euroneuro.2015.09.020. Epub 2015 Oct 9.

PMID:
26476706
5.

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC.

Arch Gen Psychiatry. 2007 Feb;64(2):193-200.

PMID:
17283286
6.

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.

Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN.

Bipolar Disord. 2012 Aug;14(5):478-87. doi: 10.1111/j.1399-5618.2012.01033.x. Review.

PMID:
22834460
7.

Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.

Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF.

Biol Psychiatry. 2004 Sep 1;56(5):340-8.

PMID:
15336516
8.

Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.

Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ.

Biol Psychiatry. 2007 Mar 15;61(6):806-12. Epub 2007 Jan 8.

PMID:
17210135
9.

Applications for magnetic resonance imaging in bipolar disorder.

Renshaw PF.

CNS Spectr. 2007 Jun;12(6 Suppl 8):9-12. Review. No abstract available.

PMID:
19317012
10.

Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study.

Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF.

Neuropsychopharmacology. 2009 Jun;34(7):1810-8. doi: 10.1038/npp.2009.2. Epub 2009 Feb 4.

11.

Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy.

Shibuya-Tayoshi S, Tayoshi S, Sumitani S, Ueno S, Harada M, Ohmori T.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):249-56. Epub 2007 Aug 22.

PMID:
17913322
12.

Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.

Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS.

Biol Psychiatry. 2005 Dec 15;58(12):969-73. Epub 2005 Jul 25.

PMID:
16043137
13.

7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.

Thakkar KN, Rösler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF.

Biol Psychiatry. 2017 Mar 15;81(6):525-535. doi: 10.1016/j.biopsych.2016.04.007. Epub 2016 Apr 19.

PMID:
27316853
14.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
15.

Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.

Bielau H, Steiner J, Mawrin C, Trübner K, Brisch R, Meyer-Lotz G, Brodhun M, Dobrowolny H, Baumann B, Gos T, Bernstein HG, Bogerts B.

Ann N Y Acad Sci. 2007 Jan;1096:157-69.

PMID:
17405927
16.

Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression.

Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, Falini A, Radaelli D, Scotti G, Smeraldi E.

Psychiatry Res. 2009 Sep 30;173(3):238-42. doi: 10.1016/j.pscychresns.2008.08.004. Epub 2009 Aug 13.

PMID:
19682864
17.

MR spectroscopic studies of the brain in psychiatric disorders.

Maddock RJ, Buonocore MH.

Curr Top Behav Neurosci. 2012;11:199-251. Review.

PMID:
22294088
18.

Systematic regional variations of GABA, glutamine, and glutamate concentrations follow receptor fingerprints of human cingulate cortex.

Dou W, Palomero-Gallagher N, van Tol MJ, Kaufmann J, Zhong K, Bernstein HG, Heinze HJ, Speck O, Walter M.

J Neurosci. 2013 Jul 31;33(31):12698-704. doi: 10.1523/JNEUROSCI.1758-13.2013.

20.

Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder.

Brady RO Jr, McCarthy JM, Prescot AP, Jensen JE, Cooper AJ, Cohen BM, Renshaw PF, Ongür D.

Bipolar Disord. 2013 Jun;15(4):434-9. doi: 10.1111/bdi.12074. Epub 2013 May 2.

Supplemental Content

Support Center